Evan Dasilva

Evan DaSilva is a Scientist I currently at Oxford Biomedica (US) LLC since January 2023, following a role as Sr. Research Associate II in Analytical Development at Oxford Biomedica Solutions from March 2022 to February 2023. Prior experience includes positions at Homology Medicines, Inc., where Evan held various roles in Analytical Development from October 2019 to March 2022, and a Research Assistant role at Geisel School of Medicine at Dartmouth, focusing on cholera vaccine development between April 2017 and June 2019. Academic qualifications include a Master’s Degree in Genetics from the University of New Hampshire and a Bachelor of Arts in Biology from Hiram College, complemented by roles in teaching and research during graduate studies.